Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

DOI Full Paper Access

195

Citations

13

References

2024

Year

Miao‐Zhen Qiu, Do‐Youn Oh, Ken Kato, Tobias Arkenau, Josep Tabernero, Marcia Cruz Correa, Anastasia Zimina, Yuxian Bai, Jianhua Shi, Keun-Wook Lee,

Abstract

ClinicalTrials.gov NCT03777657.

References

	Year	Citations

Page 1